Antonino Musolino
University of Milan(IT)Policlinico S.Orsola-Malpighi(IT)Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)Italian Oncology Group of Clinical Research(IT)Bambino Gesù Children's Hospital(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)University of Bologna(IT)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, BRCA gene mutations in cancer, Advanced Breast Cancer Therapies, Genetic factors in colorectal cancer
Most-Cited Works
- → Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer(2008)950 cited
- → Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study(2012)366 cited
- → Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer(2021)339 cited
- → Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer(2024)191 cited
- → Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study(2018)152 cited
- → Multifactorial central nervous system recurrence susceptibility in patients with HER2‐positive breast cancer